Clinical Trials

Clinical Trials

Title:  A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate, and Levetiracetam as Adjunctive in Subjects with Partial Onset Seizures

Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.

This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #12076.


Title: Lamotrigine Extended-Release in Elderly Patients with Epilepsy

Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.

This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11191.


Title: A Randomized, Multicenter, Placebo-Controlled and Active Reference (Glatiramer Acetate) Comparison Study to Evaluate the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis

Department: Neurology. Condition: Relapse-Remitting Multiple Sclerosis. Principal Investigator: S. Ausim Azizi, MD, PhD.

This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11190.


Title: A Double-Blind, Randomized, Multicenter Efficacy and Safety Study of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures

Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.

This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #12374.


Title: A Multi-Center, Double-Blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures

Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.

This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11227.  Study Closed to Enrollment.